Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B S Pasternack

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Controlled Clinical Trials|September 1, 1984
A note on data monitoring, incomplete data and curtailed testingB S Pasternack
Journal of the National Cancer Institute|November 1, 1995
More about: a prospective study of endogenous estrogens and breast cancer in postmenopausal womenB S Pasternack
Epidemiology (Cambridge, Mass.)|January 1, 1995
Sequential tests for cohort and case-control studiesB S Pasternack
Journal of Chronic Diseases|December 1, 1972
Sample sizes for clinical trials designed for patient accrual by cohortsB S Pasternack
Journal of the National Cancer Institute|November 1, 1979
Usefulness of statistical models to assess the benefit of breast cancer screeningB S Pasternack, P Strax
American Journal of Epidemiology|July 1, 1984
Breast cancer screening data in case-control studiesN Dubin, B S Pasternack
American Journal of Epidemiology|June 1, 1986
Risk assessment for case-control subgroups by polychotomous logistic regressionN Dubin, B S Pasternack
Lancet (London, England)|July 16, 1983
Statistics, T-lymphocyte subpopulations, and haemophiliaB S Pasternack, M Marmor
Health Physics|September 1, 1979
Potential carcinogenic effects of actinides in the environmentN H Harley, B S Pasternack
Health Physics|December 1, 1972
Alpha absorption measurements applied to lung dose from radon daughtersN H Harley, B S Pasternack
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Controlled Clinical Trials|September 1, 1984
A note on data monitoring, incomplete data and curtailed testingB S Pasternack
Journal of the National Cancer Institute|November 1, 1995
More about: a prospective study of endogenous estrogens and breast cancer in postmenopausal womenB S Pasternack
Epidemiology (Cambridge, Mass.)|January 1, 1995
Sequential tests for cohort and case-control studiesB S Pasternack
Journal of Chronic Diseases|December 1, 1972
Sample sizes for clinical trials designed for patient accrual by cohortsB S Pasternack
Journal of the National Cancer Institute|November 1, 1979
Usefulness of statistical models to assess the benefit of breast cancer screeningB S Pasternack, P Strax
American Journal of Epidemiology|July 1, 1984
Breast cancer screening data in case-control studiesN Dubin, B S Pasternack
American Journal of Epidemiology|June 1, 1986
Risk assessment for case-control subgroups by polychotomous logistic regressionN Dubin, B S Pasternack
Lancet (London, England)|July 16, 1983
Statistics, T-lymphocyte subpopulations, and haemophiliaB S Pasternack, M Marmor
Health Physics|September 1, 1979
Potential carcinogenic effects of actinides in the environmentN H Harley, B S Pasternack
Health Physics|December 1, 1972
Alpha absorption measurements applied to lung dose from radon daughtersN H Harley, B S Pasternack
Pageof 9